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Abstract
PML gene was discovered as a fusion partner with retinoic acid receptor (RAR) a in the t(15:17) chromosomal translocation
associated with acute promyelocytic leukemia (APL). Nuclear PML protein has been implicated in cell growth, tumor
suppression, apoptosis, transcriptional regulation, chromatin remodeling, DNA repair, and anti-viral defense. The
localization pattern of promyelocytic leukemia (PML) protein is drastically altered during viral infection. This alteration is
traditionally viewed as a viral strategy to promote viral replication. Although multiple PML splice variants exist, we
demonstrate that the ratio of a subset of cytoplasmic PML isoforms lacking exons 5 & 6 is enriched in cells exposed to
herpes simplex virus-1 (HSV-1). In particular, we demonstrate that a PML isoform lacking exons 5 & 6, called PML Ib,
mediates the intrinsic cellular defense against HSV-1 via the cytoplasmic sequestration of the infected cell protein (ICP) 0 of
HSV-1. The results herein highlight the importance of cytoplasmic PML and call for an alternative, although not necessarily
exclusive, interpretation regarding the redistribution of PML that is seen in virally infected cells.
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Introduction
Since the discovery of the PML gene as a fusion partner with
retinoic acid receptor (RAR) a in the t(15:17) chromosomal
translocation associated with acute promyelocytic leukemia (APL)
[1–3], nuclear PML protein has been implicated in a number of
cellular processes ranging from cell growth and tumor suppression,
to apoptosis, transcriptional regulation, chromatin remodeling,
DNA repair, and anti-viral defense [4–8]. Nuclear PML is also
considered the coordinating protein of sub-nuclear structures aptly
named PML Nuclear Bodies (PML NBs) or nuclear domain 10
(ND10), which number approximately 5–30 structures per cell
[9,10]. PML NBs are host to a number of proteins involved in
transcription, cell cycle regulation, chromatin organization and
cell survival [11,12].
It is well established that certain viral infections influence the
integrity of PML NBs and result in the dispersal of PML protein.
The IE1 protein of human cytomegalovirus (HCMV), the E4-
ORF3 protein of adenovirus 5, the BZLF protein of Epstein Barr
virus (EBV), and the L-HDAg protein of hepatitis delta virus
(HDV) have all been implicated in the disorganization of PML
protein and PML NBs [13–19]. Additionally, the Z protein of
LCMV and the P protein of rabies virus have been shown to
redistribute PML to the cytoplasm [20–23]. PML protein has also
been detected in the cytoplasm of cells infected with respiratory
syncytial virus (RSV), herpes simplex type 1 (HSV-1), and HIV
[22–25]. Since the targeted mutation of PML increases the yield of
infectious viral particles [26], it is postulated that the disruption of
PML NBs and the re-localization of PML protein represents a
viral strategy to evade a cellular resistance mechanism. While these
interpretations are plausible, the origin and significance of
cytoplasmic PML during viral infection remains a largely
unresolved issue.
Theoretically, cytoplasmic PML can be derived from two
sources. First, nuclear PML may be relocated into cytoplasm by
interacting viral proteins. Alternatively, cytoplasmic PML may be
derived from a bona fide cytoplasmic PML isoform that is
expressed during viral infection. It is known that the alternatively
spliced PML gene can generate at least 6 major isoforms that have
been categorized by their varying C-terminal ends [27].
Alternative splicing of internal exons 4, 5, and 6 further increases
the number of available PML isoforms, and the loss of exon 6,
which houses a nuclear localization signal (NLS), enhances the
potential for cytoplasmic variants. Common to all PML splice
variants is the retention of exons 1–3 which contains a RING
finger domain, 2 B-Boxes, and a coiled-coil domain (RBCC)
important for PML/protein interactions [27]. Although the
various PML isoforms may have related functions due to the
retention of the functional RBCC domain, it is coming to light that
isoform-specific functions exist as in the example of PML III in
centrosome amplification [28]. More recently, a cytoplasmic
isoform of PML has been described as having a novel function in
modulating TGFb signaling [29,30]. Thus, an intriguing possibil-
ity is that the apparent re-localization of PML during viral
infection may, in part, reflect the expression of a cytoplasmic-
specific PML isoform.
One of the best-characterized viral proteins known to disrupt
PML NBs and effect PML localization is the multifunctional
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2277infected cell protein (ICP) 0 of HSV-1 (ICP0). Expression of ICP0
initiates immediately upon lytic infection and plays a key role in
the transactivation of viral and cellular genes [31]. ICP0-deficient
mutants are defective for growth at low multiplicities of infection in
cell culture, and are attenuated and fail to efficiently reactivate
from latent infection in cell culture and in animals [32].
Interestingly, depletion of PML can partially complement the
defects of an ICP0-null mutant virus [33]. ICP0 localizes near or
at PML NBs early in infection and appears to facilitate the
dispersal of nuclear PML and the proteosome-dependent degra-
dation of high molecular weight PML isoforms [25,34–36]. Some
PML isoforms, however, have been observed to be recruited to
viral replication compartments, and PML has been observed in
the cytoplasm following PML NB disruption indicating that not all
PML is degraded immediately upon infection [37,38] Up to this
point it has been generally assumed that PML found in the
cytoplasm of infected cells is derived from nuclear PML.
In this study, we characterize a unique low molecular weight
isoform of PML, PML Ib, which is not only inducible by IFNc, but
is expressed in cells infected with HSV-1. We show that PML Ib
localizes to the cytoplasm and demonstrate that the cytoplasmic
PML Ib isoform alone is capable of promoting a cellular resistance
to viral infection. Surprisingly, we find that the cytoplasmic PML
Ib isoform can suppress HSV-1 replication via an ICP0-dependent
mechanism. Our data indicate that PML Ib sequesters ICP0 in the
cytoplasm which limits viral protein accumulation and replication.
Results
A Novel PML Transcript Enriched in HSV-1 Infected Cells
Encodes a Cytoplasmic Form of PML
It is well established that PML protein localizes to subnuclear
structures known as PML NBs. When examined by indirect
immunofluorescence, the expected nuclear localization pattern of
PML was observed in uninfected MRC5 cells (Fig. 1A). As has
been previously demonstrated, IFNc treatment resulted in an
increase in size and number of PML NBs (Fig. 1B) [39,40]. In
contrast, a significant fraction of total PML protein localized to the
cytoplasm in asynchronous MRC5 cells infected with low doses of
HSV-1, as has been reported by others [37]. A careful
examination of the pattern of nuclear vs cytoplasmic PML,
however, suggests that cytoplasmic PML is not always formed at
the expense of nuclear PML (Fig. 1C). Figure 1C left panel shows
the appearance of cytoplasmic PML in a cell in which nuclear
PML displays a well characterized disorganization pattern
indicative of PML that has been recruited to stage IV replication
compartments [37]. Accumulation of cytoplasmic PML was also
seen, however, in cells with apparently normal PML NBs (Fig. 1C,
middle and right panels). These observations raised the possibility
that at least a portion of cytoplasmic PML seen in virally infected
cells is derived from a bona fide cytoplasmic PML isoform and is
not simply representative of PML that has been re-localized from
the nucleus to the cytoplasm.
Todetermineifviral infection could uniquelyaffectthe expression
of PML splice variants lacking an NLS, total RNA was harvested
from uninfected and HSV-1 (F)-infected human primary fibroblasts
(MRC5) and analyzed by Reverse Transcriptase Polymerase Chain
Reaction (RT-PCR). By using a forward primer recognizing a
sequence at the end of exon 3 of PML and a reverse primer
recognizing a sequence at the beginning of exon 9 we were able to
examine the internal exon splice variants of the PML I transcript
which is believed to be the predominant PML isoform [41]. As
shown in Figure 2A, multiple bands were generated. Most notable,
however, was the presence of a low molecular weight band seen in
HSV-1 infected cells. Cloning and subsequent sequencing of the
PCR pool revealed that the fast migrating band corresponded to a
sequence indicative of an isoform missing both exons 5 and 6.
According to conventional nomenclature, the transcript represents
the predicted PML Ib isoform [27].
Interestingly, the splicing of exons 5 and 6 in any PML isoform
variant retaining exon 7a, results in a frameshift and the
subsequent formation of a termination codon encountered in the
beginning of exon 7a. Thus, the splicing of exons 5 and 6 from
PML transcript variants I-V results in transcripts that ultimately
encode the same protein (Table 1). As such, by using a forward
primer in PML exon 3 and a reverse primer that spans the exon 4/
7a junction (see Fig. 2B) we were able to examine the expression of
several PML Ib–like transcripts. We therefore used this primer set
to quantify by real time PCR the level of PML isoforms lacking
exons 5 and 6 (collectively called cPMLD5&6) upon viral infection.
In relation to the housekeeping gene, GAPDH, cPMLD5&6
transcripts were increased 3- to 4- fold during viral infection. A
similar increase was observed after IFNc treatment (Fig. 2C, left
panel). It has long been known, however, that HSV rapidly shuts
down host RNA synthesis [42]. To circumvent the challenge of
ascertaining RNA expression in infected cells with waning levels of
housekeeping genes, real-time PCR was performed using primers
specific for the cPMLD5&6 transcripts along with primers that
recognize all PML isoforms (primers derived from exon 3) to
compare the expression of cPMLD5&6 to total PML transcripts
Figure 1. Accumulation of cytoplasmic PML in HSV-1 infected cells. Localization of PML was examined by indirect immunofluorescence
microscopy in mock infected, infected (1.0 or 0.1 PFU/cell HSV-1) and IFN-c treated MRC5 cells. Cells were fixed 24h post treatment and
immunostained with anti-PML (PG-M3) and Texas- Red conjugated secondary antibody. DAPI was used to counter-stain the nucleus.
doi:10.1371/journal.pone.0002277.g001
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quantification of cPML showed that cPMLD5&6 mRNA was
enriched approximately 20 fold when cells were infected at 1.0
PFU/cell. Likewise, absolute quantification analysis of
cPMLD5&6 demonstrated that approximately 25% of total PML
in virally infected cells are cPMLD5&6 (Fig. 2C, right panel).
Given the large number of PML isoforms that are expressed in
infected cells, it is clear that cPMLD5&6 constitutes a major
fraction of PML that exists during viral infection.
Localization of PML Ib and its Effects on Nuclear PML
Because the nuclear localization sequence (NLS) for PML is
located on exon 6 it was of interest to determine how the deletion
of exons 5&6 effected the localization of PMLIb. The sub-cellular
localization of PMLIb was verified by generating a human PMLIb
/pcDNA 3.1 Hygro construct which was used to transfect murine
PML
+/+ and PML
2/2 fibroblasts. PMLIb was then visualized
using an antibody specific for human PML. Confocal analysis
indicated that PMLIb localizes at or adjacent to the nuclear
membrane and can assume a hollow sphere shape (Figure 3A top,
left panel) Immunofluorescence microscopy of PMLIb in stably
transfected in murine fibroblasts revealed a perinuclear distribu-
tion with a distinct localization of PMLIb to discrete sites in the
cytoplasm regardless of whether the cell expressed endogenous
PML (Fig. 3A compare PML
+/+ & B1041-1, to PML
2/2 cells
bottom left panel). Thus, the cytoplasmic localization of PMLIb is
not dependant on its interaction with other PML isoforms.
Interestingly, however, when the PMLIb cDNA was co-transfected
with cDNAs encoding predominantly nuclear localizing PML
isoforms (PML I, IV, and VI, Figure 3B) the cytoplasmic PML
aggregates appeared significantly larger and surrounded the entire
nucleus (Fig. 3C). Furthermore, when an anti-mouse PML
antibody was used to visualize endogenous PML, it became clear
that the human PMLIb isoform was capable of re-localizing
endogenous PML (Fig. 3C rightmost panel). To further investigate
the interaction of cytoplasmic and nuclear PML isoforms a V5-
epitope-tagged PML I plasmid and a myc-epitope-tagged PML Ib
plasmid were constructed. The differentially tagged constructs
were transiently transfected alone or combined into HEK293 cells,
and cell lysates were subsequently subjected to co-immunoprecip-
itation with antibodies specific for the myc or V5 tags. A stable V5-
PML I/Myc-PML Ib heterodimer would contain both isoforms
when precipitated with the V5 antibody and blotted with the myc
antibody. As shown in figure 3D (right panels, far right lanes
marked I+Ib), anti-V5 co-immunoprecipitated V5-tagged PML I
and myc-tagged PML Ib following transient co-transfection. As
Figure2.Endogenousexpressionofcytoplasmic PML is enhancedin virallycells. TotalRNA was extracted fromMRC5 cells24 h after exposure
toHSV-1(F)at0.1,1.0,and/or10PFU/cell.MockinfectedcellsandcellstreatedwithIFN-cwereusedascontrols.ExpressionofPMLItranscriptvariantswas
determined by RT-PCR using a primer set located in exon 3 and exon 9 of PML. (A) Southern blot analysis using a PML cDNA probe was used to enhance
signal detection (25 PCR cycles). (B) Depiction of the three PML I transcript variants identified after cloning and sequencing, and the relative locations of
theprimersets.(C)RT-realtimePCRwasperformedusingaforwardprimerlocatedinexon3,andareverseprimerspanningtheexon4-7ajunctionofPML
to specifically amplify cPMLD5&6 in MRC5 cells upon viral infection or IFN-c treatment. Left panel: Relative quantification of cPML expression was
normalized with GAPDH. Middle panel: Relative quantification of cPML expression was normalized with total PML using a primer set in exon 3 that
amplifies all PML transcripts. Relative expression was determined using the mock sample as the calibrator. Right panel: Ratio of cPML to total PML. PMLI
and PML Ibstandards were seriallydiluted togeneratea STD curve containingat least 6 points. The copy number of each standard was determined using
the following formula: (X g/ul DNA/[plasmid length in basepairs6660])66.022610
23. A STD curve was generated based on a LOG10 to Ct curve. The
average Ct value of each sample was used to extrapolate a Log based 10 value which was subsequently converted to molecules/ uL. These values were
then used to determine the ratio of cPML D5&6 to total PML (results are representative of two separate trials)
doi:10.1371/journal.pone.0002277.g002
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anti-V5 antibody and detected by immunoblot with anti-V5
antibody, but not with the anti-myc antibody (compare top &
bottom right panels, second lane marked ‘I’). Likewise, myc-tagged
PML Ib alone could not be detected by immunoblot with the anti-
myc antibody after immunoprecipitation with anti V5. Similar
results were observed using a V5-epitope-tagged PML IV
construct (data not shown). Our attempts to carry out reciprocal
analysis using anti-myc to co-precipitate V5 tagged PML were
unsuccessful. Nonetheless, it appears that a physical association
can occur between nuclear and cytoplasmic PML isoforms. As a
follow-up to the above studies, indirect immunofluorescence was
used to assess the localization pattern of co-transfected PML Ib-
myc tagged and PML I-V5 tagged cDNAs. As shown in figure 3E,
single staining for PML Ib using the anti-myc antibody, 9E10,
demonstrated that PML Ib primarily localizes to cytoplasmic dots
or rings when transfected alone, but assumes a perinuclear
distribution when co-transfected with PML I. Likewise, single
staining for PMLI, using anti V5 antibody showed that PMLI also
tends to distribute towards a perinuclear localization pattern when
co-transfected with PML Ib, but is mostly found in nuclear dots
when transfected alone. Although single stain analysis also revealed
nuclear dot formation in co-transfected cells, anti-myc was unable to
detect PML I when transfected alone and anti V5 failed to detect
PML Ib when transfected alone (data not shown). Together, these
findings confirm that the PMLIb isoform predominantly localizes to
discrete sites in the cytoplasm and to sites near or at the nuclear
membrane, and that a physical association can occur between
nuclear and cytoplasmic PML isoforms that can affect the
localization pattern of both isoforms.
PMLIb as an Effector Molecule in the Cellular Antiviral
Defense against HSV-1
We used stable cell lines over expressing PML I or PML Ib to
examine the consequences of over-expression of nuclear PML
(PML I) or cytoplasmic PML (PML Ib) on viral protein
accumulation by immunoblot (diagramed in Fig. 4A). As shown
in Figure 4B, after selection, the cells had uniform transfection and
protein localization for nuclear PML I and cytoplasmic PML1b.
The levels of both the immediate early (ICP0) and late (Us11)
HSV-1 viral proteins were reduced in cells expressing PML Ib
when cells were infected with HSV 1 in different time points post
infection (Fig. 4C). These results demonstrate that PML Ib can
impede the accumulation of both early and late viral protein levels
when challenged with HSV 1. In contrast, PML I did not display
anti-viral activity. Surprisingly, we consistently observed a slight
enhancement of viral protein accumulation in cells transfected
with PML I alone.
Concomitant with the above experiment, we titrated the
material from HSV-1 infected PML I, or PML Ib -transfected
cells and used it to re-infect VERO cells to determine the effect of
PML isoforms on viral production. As shown in Figure 4D, ectopic
expression of PML Ib resulted in an approximate 10-fold
reduction in viral titer compared to vector control and PML I-
expressing cells. Taken together, these results demonstrate that
PML Ib limits viral protein accumulation and virus replication. In
contrast, the predominantly nuclear localizing PML I isoform
alone does not confer an antiviral effect.
To determine whether the function of PMLIb depends on
endogenous PML, PML Ib was transfected into PML
2/2 fibroblasts
a n dc o m p a r e dw i t hP M L
+/+ and PML
2/2 cells for their
susceptibility to HSV. As shown in Fig. 5A, targeted mutation of
PML caused an approximate 100-fold increase in HSV yield over a
24-hour period. Transfection of PMLIb, however, completely
abrogated the increase. Thus, in this model, PMLIb is largely
responsible for the anti-viral effect of the Pml locus.
In order to directly compare PMLI, PMLIb and PMLI+Ib for
their abilities to confer resistance to viral infection, PML
2/2
fibroblasts were transfected with either PML I and/or PML Ib and
then infected with HSV-1(F). Cells were harvested 24 h post
infection to compare viral protein accumulation. As shown in
Table 1. Predicted open reading frames of the various internal splice variants of PML: Five different PML transcripts ultimately
generate the same protein product.
Isoform Exons ORF (bp) Nomenclature
Fl D5 D56 D456
PML I 1-2-3-4-5-6-7a-8a-9 2646 2502 1269 2172 TRIM19 alpha [63]; PML-1 [64]; PML4 [65]; variant1 (NCBI)
(882aa) (834aa) (423aa) (724aa)
PML II 1-2-3-4-5-6-7a-7b 2472 2328 1269 1998 TRIM19 gamma [63]; PML-3 [64]; variant 3 (NCBI)
(824aa) (776aa) (423aa) (666aa)
PML III 1-2-3-4-5-6-7a-7ab-7b 1923 1779 1269 1449 PML-L [2]
(641aa) (593aa) (423aa) (483aa)
PML IV 1-2-3-4-5-6-7a-8a-8b 1899 1755 1269 1425 TRIM 19 zeta [63]; PML3 [65]; Myl [66]; variant 6 (NCBI)
(633aa) (585aa) (423aa) **(475aa)
PML V 1-2-3-4-5-6-7a-7ab-RI 1833 1689 1269 1359 TRIM19 beta [63]; PML-2 [64]; PML1 [65]; variant 2 (NCBI)
(611aa) (563aa) (423aa) (453aa)
PML VI 1-2-3-4-5-6-RI-7a 1680 1536 1473 1506 TRIM19 epsilon [63]; PML-1 [3]; PML-3b([64]; variant 5 (NCBI)
(560aa) (512aa) *(491aa) (502aa)
Notes:
TRIM 19 iota & TRIM 19 eta (aka variant 7) both labeled PML VI b by Jensen [27]=PML Ib-like transcripts
*PML VI contains intron sequence GTAGGGAG before exon 7a such that a PML Ib-like isoform is not generated
**cPML isoform connected with TGF-b signaling [29]
Table adapted from Jensen et.al, 2001.
doi:10.1371/journal.pone.0002277.t001
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levels. In contrast, PMLI caused a slight increase in the synthesis of
viral proteins. When the two cDNA were co-transfected, PMLIb
abrogated the increase caused by PMLI.
To evaluate the endogenous role of PML Ib and establish
physiological relevance, we selectively blocked PML Ib biosynthe-
sis in infected primary fibroblasts using a siRNA oligonucleotide
specific for the junctional region of exon 4 and 7a that is found
exclusively in PML Ib-like transcripts. Compared to a negative
siRNA control, nucleofection of cPML D5&6 siRNA resulted in a
more than 80% reduction in cPML D5&6 transcripts (Fig 6A). The
specificity of the siRNA was confirmed using primers that
recognize all PML isoforms. As expected, the siRNA for cPML
D5&6 caused only a partial reduction on total PML mRNA in
mock-infected cells. More importantly, knock down of PML Ib
(cPML D5&6) resulted in a substantial increase in ICP0 viral gene
expression when infected with HSV-1 (Fig. 6B). These data
establish that endogenous PMLIb plays a critical role in the
cellular resistance to viral infection.
PMLIb Exerts its Antiviral Function through an ICP0-
Dependent Mechanism
Previous reports have clearly established that a unique
relationship exists between ICP0, PML and PML NBs in HSV-1
infected cells. Namely, ICP0 appears to migrate from the
cytoplasm to target nuclear PML and PML NBs relatively early
in infection [34,36]. To determine if the antiviral properties of
Figure 3. PML Ib primarily localizes to the cytoplasm and influences the localization of nuclear PML isoforms. (A) Immunolocalization of
PML Ib. PML
+/+ PML
2/2, and B1041-1 mouse fibroblast cell lines transfected witha human PML Ib/pcDNA3.1 construct were immunostained withPG-M3
to determine the intracellular localization of PML Ib by confocal (PML
+/+) and indirect (PML
2/2 and B1041-1) immunofluorescence microscopy. DAPI was
used to counter-stain the nucleus. (B) Localization of PML isoforms I, IV, and VI was revealed by immunostain with PG-M3 and Texas Red following the
transfection of each cDNA into B1041-1 cells. (C) Co-transfection of PMLIb with nuclear PML isoforms induces a redistribution of PML protein to the
cytoplasm: PMLIb+PML I (stabletransfectant,left image); PMLIb+PML IV (transient transfection, middle image); PMLIb+PML VI (transienttransfection,right
image). Cells wereimmunostained withPG-M3 andTexas red conjugatedsecondary antibody as above. Notethatthe cells transiently co-transfectedwith
PML Ib+PML VI (leftmost image) are dual stained withPG-M3 and a murine polyclonal PML antibody and showre-localization ofendogenousmouse PML.
DAPI was used to counter-stain the nucleus. Localization of PML was examined by indirect immunofluorescence microscopy. (D & E) Interaction between
nuclear and cytoplasmic PML isoforms. V5-tagged PML I/ pcDNA 4, myc-tagged PML Ib/pcDNA 3.1 and vector constructs were transiently transfected
either alone with vector or in combination, into the HEK293 cell line. 48h post-transfection cells were (D) lysed and subjected to co-immunoprecipitation
or (E) fixed and immunostained. (D) V5 and myc antibodies were used for immunopreciptiations while HRP-conjugated V5 and myc antibodies were used
for immunoblots. As shown in the bottom right panel, myc-tagged PML Ib co-precipitated with V5-tagged PMLI, whereas transfection of PML I or PML Ib
alone did not result in co-immunoprecipitation. Panels on the left (top & bottom) represent immunoblots of the crude lysates (10 mgp r o t e i n / l a n e ) ,a n d
are included to show the antibody specificity for the V5-tagged PML I and Myc-tagged PML Ib constructs. V=vector control, I=PML I, Ib=PML Ib,
I+Ib=co-transfected PML I & PML Ib. (E) Cells co-transfected with both vectors, PML I-V5+pcDNA 3.1-myc, PML Ib-myc+pcDNA 4-V5-his, or PML I-V5+PML
Ib-myc and grown on glass cover slips were single stained with a FITC conjugated V5 antibody (bottom two panels), or the anti-myc antibody, 9E10, and
anti mouse Texas Red (top two panels) as indicated in the figure.
doi:10.1371/journal.pone.0002277.g003
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and PML I+Ib on the replication of the HSV-1 ICP0-null mutant
R7910 with the WT virus HSV-1(F). While PML Ib and PML
I+Ib caused a substantial reduction in the accumulation of
glycoprotein B (gB) and US11 when infected with HSV-1 (F), no
such effect was observed in the infection by R7910 (Fig. 7A).
Likewise, inhibition of viral titer was also ICP0-dependent
(Fig. 7B). These results demonstrate that ICP0 plays an essential
role in the PML Ib-mediated suppression of HSV infection.
To understand the cellular basis for the molecular interaction, we
first examined the localization of PML Ib and ICP0 during HSV-1
(F) infection. Since high concentrations of the PG-M3 antibody are
known cross-react with the immediate early HSV-1 protein ICP4
[43], great care was taken to use a lower concentration of antibody
for these studies. Thus, fluorescence was not observed in PG-M3
stained, HSV-1(F) infected, vector control cells (Fig. 8A). In HSV-1
infected cellsco-transfected withPMLI+PMLIb,anti-ICP0staining
was clearly delineated from staining with the anti-PML antibody
(Fig. 8B). Therefore, the staining conditions were clearly able to
distinguish between PML and ICP0 proteins. As shown in Fig. 8C,
cells over-expressing nuclear PML I showed a typical pattern of
localization that agrees with earlier reports [41]: by 2h post
infection, both ICP0 and nuclear PML co-localized at ND10. By
28h post infection, the PML I that could be visualized was dispersed
diffusely but still confined in the nucleus, while ICP0 assumed a
speckled pattern in the cytoplasm. In contrast, co-localization of
PML Ib and ICP0 could be found throughout the course of
infection in PML Ib transfected cells (Fig. 8D). Z-stack confocal
analysis showed remarkable co-localization of ICP0 and PML
within the cytoplasm (Fig. 8E).
Figure 4. PML Ib can function in the cellular anti-viral defense against HSV-1. (A) A schema of the cellular model and infection protocol. (B)
B104-1-1 cells were transfected with vector, PML I, or PML Ib. Stable cell clones were selected. PML I and PML Ib cells were immunostained with PG-
M3. (C and D). Stable cell clones were infected with 0.01 PFU/mLHSV-1 -F. Infected cells were harvested at the indicated times for Western blot
analysis (C), and analysis of viral tier (D). Expression of PML Ib reduced viral protein production in cells infected with HSV-1(F) (C). Protein lysates
(10 mg/sample) were separated by electrophoresis and blotted with antibodies against the HSV-1 viral proteins ICP0 and US11. b-Actin was used as
loading control. (Results are representative of multiple experiments.) (D) Viral titers at different time points were determined in triplicate by standard
plaque assay using VERO cells.
doi:10.1371/journal.pone.0002277.g004
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we reasoned that sequestration of ICP0 in the cytoplasm might be
one mechanism by which PML Ib reduced expression of HSV-1
genes including ICP0. To test this hypothesis, we quantitated the
amounts of ICP0 and Us11 transcripts in HSV-1 infected PML I
and PML Ib cells by real-time PCR. As shown in Fig. 9A, a clear
reduction of both transcripts was observed in PML Ib expressing
cells 12 and 24h post infection. Conversely, PML I significantly
enhanced ICP0 and Us11 transcript levels. To determine whether
PMLIb affected degradation of ICP0, we treated HSV- 1 infected
cells 12 hours after infection with cycloheximide and measured the
amounts of protein at 2, 4 and 6 hours after the treatment. As
shown in Fig. 9B, similar decay rates were observed in vector and
PMLIb-transfectants. Therefore, rather than effecting the half life
of ICP0 protein, it appears that PMLIb contributes to the cellular
antiviral response by reducing the transcription of viral proteins
via the sequestration of ICP0 in the cytoplasm.
Discussion
It is well established that infection by a variety of viruses is
associated with the disruption of PML nuclear bodies and the
appearance of PML protein in the cytoplasm. It has been largely
assumed that PML found in the cytoplasm of infected cells is
derived from virally re-localized nuclear PML and represents a
mechanism by which viruses evade the cellular defense. Here we
present several lines of evidence that accumulation of cytoplasmic
PML also represents a mechanism of cellular resistance to viral
infection, and what was formerly interpreted as the relocation of
nuclear PML is at least partially indicative of a bona fide
cytoplasmic PML isoform (or isoforms) that lack a nuclear
localization sequence collectively called cPMLD5&6.
We initially demonstrated that infection by HSV-1 (F) results in
the selective enrichment of cytoplasmic isoform variants lacking
exons 5 and 6, and that a novel PMLD5&6 variant, PML Ib is
expressed during HSV infection. Although we have observed that
PML Ib can be induced by IFNs, our quantitative analysis by real
time PCR indicated that IFN-c increased all PML isoforms, while
HSV-1 infection favored an increased ratio of cPMLD5&6 to total
PML. Thus, after 24 hours of IFN treatment cPMLD5&6 levels
Figure 5. cPML exerts an antiviral effect against HSV-1. (A). PML
2/2, PML
+/+, and PML
2/2 cells stably over-expressing PML Ib were
exposed to 0.1 PFU/mL HSV-1 (F) and harvested 2, 12, and 24 h post
infection. Viral titers were determined in Vero cells. (B). PML (
2/2) cells
were transfected with vector, PML I, PML Ib or co-transfected with PML I
and PML Ib. Polyclonal cells were drug selected and exposed to 1.0
PFU/cell HSV-1 (F) infection. 24 h post infection, cells were harvested
and Western blot analysis was performed using antibodies to ICP0,
Us11, and b-Actin.
doi:10.1371/journal.pone.0002277.g005
Figure 6. Perturbation of cPML by RNAi effects the accumulation of HSV-1 viral proteins. (A) Relative expression of the coding transcripts
for cPML or total PML in MRC5 cells 96 h post nucleofection of siRNA specific for cPML (siPML Ib). Bars are grouped based on the primer sets used to
detect the relative expression of cPML. Data are representative of at least two separate trials. (B). MRC5 cells nucleofected with a negative control
siRNA (siS) or siRNA for cPML (PML Ib) were exposed to 1.0 PFU/cell wild type HSV-1 [HSV-1 (F)], or the ICP0
2/2 HSV-1 mutant strain R7910. 24 h post
infection, cell lysates were harvested for Western blot analysis of the HSV-1 viral protein ICP0. b-Actin was used as a loading control.
doi:10.1371/journal.pone.0002277.g006
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infection, cPMLD5&6 transcripts represented about 25% of all
PML transcripts. Given the large number of potential PML
isoforms, it appears that cPMLD5&6 constitutes a major form of
PML that exists during viral infection.
We subsequently demonstrated that PML Ib primarily localizes
to discrete dots in the cytoplasm and near or at the nuclear
membrane. PML Ib not only showed a predominant cytoplasmic
localization, it also significantly effected the localization of the
PMLI isoform raising the intriguing possibility that cPMLD5&6
may also effect the localization of predominantly nuclear PML
isoforms during viral infection. Whether the shift in PML isoform
transcript levels during HSV-1 infection can perpetuate the
transformation in PML localization pattern remains to be
determined. However, we have also observed that unlike PML
isoforms I-VI, the protein product of PML Ib is not subject to
modification by SUMOI (unpublished observations). Thus, is it
also possible that this isoform is spared from ICP0 induced
degradation of SUMOylated PML isoforms.
Interestingly, cytoplasmic PML dots similar to the staining
pattern for PML Ib have been identified in the G1 phase of the cell
cycle [44]. Furthermore, HSV-1 infection is known to arrest cells
in G1 [45]. Thus, it will be very interesting to determine the
identity of the PML isoform(s) responsible for the cytoplasmic
bodies generated in G1. It is also important to note that HSV-1
infection results in the inhibition mRNA splicing early in infection
largely through the action of the UL 54 gene product ICP27
[46,47]. . Like ICP0, ICP27 also regulates viral gene expression
and can shuttle between the nucleus and cytoplasm [48,49]. It is
therefore of interest to test whether generation of PMLIb and
other potential cPML isoforms can be mediated by ICP27, and
whether or not cPML effects ICP27 function.
We next showed that the transfection of PML Ib, but not
nuclear PML I, distinctly hindered viral replication. In our model
system, PML Ib caused a 10 fold reduction in viral titer as well
as a clear-cut reduction in the accumulation of viral proteins
representative of both immediate early and late times in
infection. Thus, our data helps explain a paradox regarding
PML function. So far, although studies using PML
2/2 systems
have demonstrated that PML protein is clearly part of an
intrinsic cellular response against HSV-1 [33,50], over-expression
studies using nuclear PML isoforms (III , IV,V, & VI) have failed
to show that any one nuclear PML isoform alone can exert such
a response [24,33,51,52]. In contrast, we observed that
Figure 7. The antiviral properties of cPML are dependent on ICP0. (A) Western-blot analysis comparing viral protein expression of gB and
Us11 in B1041-1 cells stably over-expressing various PML isoforms and exposed to wild type HSV-1 (F) (left panel), or the ICP0
2/2 HSV-1 virus R7910
(right panel). (B) Comparison of viral growth in cells over-expressing PML and exposed to 0.1 PFU/mL of wild type HSV-1 (F), or the ICP0
2/2 mutant
virus R7910. Viral titers were determined in triplicate by standard plaque assay using Vero cells. P values were determined using two-sided
independent sample t-tests comparing results to vector control (** P,0.001).
doi:10.1371/journal.pone.0002277.g007
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response against HSV-1. Corroborating the above findings, we
found that over-expression of the predominantly nuclear
localizing PML I isoform alone did not exert an antiviral
function against HSV-1. In fact, we consistently observed a slight
enhancement of viral proteins indicative of both immediate early
and late phases of viral infection in HSV-1 infected PML I over-
expressing cells. PML I is believed to be the prototypic PML
isoform [41]. Our observations showed that the cellular
localization pattern of this isoform in progressively infected cells
mimics the localization pattern observed for viral proteins
involved in stage IV HSV-1 replication compartments. There-
fore, it is possible that this particular PML isoform is recruited to
viral replication compartments and that a function of PML I, is
exploited by the virus. How PMLI enhances viral transcription,
however, remains to be determined.
We additionally demonstrated that the combination of PML I and
PMLIb (whichresultsinacytoplasmicexpressionpattern)alsoexerts
an antiviral effect. We also observed that this effect was stronger in
PML
+/+ verses PML
2/2 cells suggesting the need for other PML
isoforms (compare Fig. 7A and B with Fig. 5B). Overall, however, it
appeared that the effect of PML Ib was dominant. In this regard,
although a small minority of PML in PML I expressing cells can be
found in localizing to perinuclear sites as predicted by the NES
contained in exon 9 of the PML I isoform [41,53] we showed, in co-
transfection studies, that PMLI is drastically redistributed to the
cytoplasm in the presence of PML Ib.. Likewise, transfected PMLIb
also relocated endogenous PML from the nucleus to cytoplasm in a
localization patternconsistent with previous observations [38,54–56].
Since specific knock down of PML Ib enhanced viral protein
accumulation in untransformed human fibroblasts, it is clear that
this isoform is an intrinsic component of the cellular antiviral
Figure 8. Localization of PML I or PML Ib and ICP0 in HSV-1 infected cells. (A and B). B104-1-1 cells were stably transfected with PMLIb and
exposed to 0.1 PFU/cell HSV-1(F). Cells were fixed 28h post infection. Dual color immunofluorescence staining was performed with PG-M3 (diluted
1:150) (red), and anti-ICP0 antibody (green). Chromosomal DNA was counterstained with cytox orange. Viral proteins were not detected by the PG-
M3 antibody in HSV-1 infected Vector control cells (A), and ICP0 stained uniquely from PML in HSV-1 infected PML I+PML Ib co-transfected cells
(compare the heavily infected cell in upper right to the recently infected cell in the lower left corner) (B). (C and D) B104-1-1 stably transfected with
PML I (C) or PML Ib (D) were exposed to 0.1 PFU/cell HSV-1 (F). Cells were fixed at 2h and 28h post infection as indicated. Images were captured with a
Zeiss 510 LSM confocal microscope. (E) Further analysis using the LSM Image Browser software demonstrates co-localization of PML Ib and ICP0 in the
cytoplasm of a PML Ib expressing cell infected for 28 h with 0.1 PFU/cell. Red and green represent PML Ib and ICP0 respectively, while cytox orange
staining is represented by blue in both the upper image and intensity profile (bottom). The intensity profile was software generated from the
fluorescence intensity values encompassed along the red line (upper image).
doi:10.1371/journal.pone.0002277.g008
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that a cytoplasmic PML isoform can function in antiviral defense.
It is possible that the importance of cPML has been over-looked in
many studies as a result of the lack of available antibodies that can
successfully detect multiple endogenous PML isoforms. For
example, the anti-PML antibody, 5E10, which is exceptional at
recognizing multiple endogenous PML isoforms, unfortunately
recognizes an epitope in exon 5 which is lacking in the cPML
isoforms [57,58]. Despite this, several studies have demonstrated
an association between cellular antiviral defenses and cytoplasmi-
cally localized PML. In one study, over-expression of a
cytoplasmic PML deletion mutant was capable of reducing
mRNA, protein synthesis, and viral production in cells infected
with influenza virus and VSV [59]. More noteworthy, human
immunodeficiency virus (HIV) was shown to trigger an immediate
cytoplasmic redistribution of PML that might interfere with the
early steps of viral replication [23].
Lastly, our results in HSV-1 infected cells indicated that ICP0 is
a target of cPML and that cPML causes the cytoplasmic
sequestration of ICP0. ICP0 is an important transactivator for
the transcription of viral genes including itself [31]. Our data
demonstrate that PML Ib exerts its antiviral activity by decreasing
viral gene expression via the cytoplasmic sequestration of ICP0
rather than by altering the half-live of ICP0.
A related possibility is that the sequestration of ICP0 via PML
Ib affects the ability of ICP0 to disrupt PML NBs (ND10s) and/or
to degrade nuclear PML, which has been implicated in
transcriptional repression. Since the antiviral property of cPML
occurs in cells without endogenous PML, our data suggest that this
is not the primary mechanism by which PML Ib impairs viral
growth. Yet, it has recently been demonstrated that ICP0 targets
to (and subsequently disrupts) de novo ND10-like structures in the
absence of PML [33], thus, the cytoplasmic sequestration of ICP0
mediated by PML Ib may assist the cellular antiviral defense by
protecting additional ND10 resident proteins.
In summary, our data establishes a novel function for
cPMLD5&6 in viral infection that involves the immediate early
HSV-1 protein ICP0. Given the essential role of ICP0 in
controlling viral gene expression and latency, an intriguing
question raised by these studies is the possibility that cPMLD5&6
also impacts other diseases associated with recurrent viral
infections. Since the disruption of PML NBs have been reported
for a number of viruses, it is likely that these conclusions are not
restricted to HSV-1 and are of general significance to our
understanding of the cellular resistance to viral infection.
Materials and Methods
Cells and viruses
B104-1-1 cells, derived from NIH3T3 cells, were obtained from
the American Type Culture Collection (ATCC) and cultured at
37uCin10%CO2inDulbecco’smodified Eagle’smedium (DMEM)
supplemented with antibiotics, glutamine and 10% calf serum. All
other cell lines were cultured at 37uCi n5 %C O 2.H E K 2 9 3a n d
MRC5 cells were obtained from ATCC and cultured according to
ATCC recommendations. PML deficient (pml
2/2)m o u s eT
antigen-immortalized fibroblasts (PML
2/2cells) were maintained
in DMEM and 10% FBS [9].
HSV-1 strain F [HSV-1 (F)] was used in these studies [60].
R7910, a gift of B. Roizman, is a recombinant virus derived from
HSV-1 (F) from which both copies of the ICP0 gene have been
deleted [61]. Propagation and titration of viruses were carried out
using African green monkey kidney (Vero) cells (ATCC) that were
maintained in DMEM plus 5% newborn calf serum (NCS).
Antibodies
The following antibodies were used: mouse monoclonal anti-
PML, PG-M3 (Santa Cruz Biotechnology), mouse monoclonal
anti b-Actin (Chemicon), and antibodies to HSV-1 proteins ICP0
(1112) and gB (Goodwin Institute). Antibodies to ICP0 Exon 2
Figure 9. PML Ib reduces accumulation of viral transcripts but
not ICP0 half-life. (A) Determination of ICP0 and Us11 expression in
HSV-1 infected PML stable cell lines was determined via RT-real time-
PCR. Stable cell lines containing PML I, PML Ib, PML I+PML Ib, or vector
alone were seeded at 5610
6 cells per well in 6-well clusters and
exposed to 0.01 PFU/cell of HSV-1 strain F diluted in mixture-199
(Gibco/Invitrogen) supplemented with 1% calf serum. After 1 hr
incubation at 37uC, monolayers were cultured at 37uC and cells were
harvested for isolation of total RNA at the indicated times. Murine 18S
ribosomal RNA was used as the endogenous control. Data are
representative of 2 separate trials. (B) PML Ib expression does not
enhance the degradation of ICP0. Cell expressing PML Ib or vector
control were exposed to 0.1 PFU/cell of HSV-1 (F). 12 h post infection,
cells were treated with cyclohemimide (CHX) and protein lysates were
harvested at the indicated times to monitor the expression of ICP0 by
immunoblot. b-Actin was used as a loading control.
doi:10.1371/journal.pone.0002277.g009
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antibody to mouse PML was generated by immunization of a
hamster with inclusion body from bacteria pLysBL21 containing
plasmid pET32mPML which represents a full length murine PML
isoform containing exon 1-9.
Plasmid construction
Plasmid PMLVI/EBO was kindly provided by R. M. Evans.
The PML VI sequence was inserted into the pcDNA3.1 Hygro
vector (Invitrogen) as a Not I fragment to generate PML VI/
pcDNA 3.1 Hygro. The rest of the PML plasmid constructs used
in this study were generated by exchanging alternate 39 ends
representing isoforms PML I, Ib, and VI onto the 59 sequence of
PML IV corresponding to PML exons 1-3. DNA fragments
specifying residues of the various carboxy-terminal regions of PML
were generated as RT-PCR products that were subsequently
cloned into the pNoTA/T7 (Eppendorf) or TOPO 2.1 vector
(Invitrogen). The various PML constructs, ultimately housed in the
pcDNA 3.1 vector using a triple ligation strategy, were designed to
match the following sequences found in the NCBI data base (PML
I: gi/190116/; PML Ib: gi/12275902/; PML IV:gi/12275904/;
PML VI: gi/67089163/ ). Primers for plasmid construction are
available upon request.
Transfection studies
Cells were seeded 3610
5 cells per well of a six well cluster. Cells
were transfected with 1 mg of PML Ib/pcDNA3.1 or PML I/
pcDNA3.1 plasmid, both constructs, or pcDNA3.1 (vector control)
using FuGene 6 according to manufacturers protocol (Roche
Diagnostics Corp.). Transiently transfected cells were harvested for
analysis after 48 h incubation at 37uC. Polyclonal PML
2/2
transfectants were cultured for two weeks in selective media
containing 200ug/ml Hygromycin B, while stable clonal cell lines
were generated by selecting for cells capable of growing in a
limited dilution and in media supplemented with 100 or 200 mg/
ml Hygromycin B (Invitrogen).
RT-PCR and RT-real time PCR
Analysis of endogenous PML transcripts. MRC5 cells were treated
with or without IFN-c (1000 IU/ml, R&D systems, Inc.) for 24 h,
or subject to various concentrations of HSV-1 for 24 h. Total
RNA was isolated from the MRC5 cultures using Trizol reagent
(Invitrogen, Carlsbad, CA) according to manufacturers instruc-
tions. The various splice forms of the PML I transcript were
amplified by RT-PCR using the following primers: hPMLE3F 59-
CTTGCATCACCCAGGGGAAA39 (sense), and hPMLE9R 59-
CCGGTTCACCGCAGCCAGCT-39 (antisense). Real-time PCR
analysis was performed using the Applied Biosystems ABI PRISM
7700 Sequence detection System with gene and isoform specific
primers in the presence of Cybergreen (BioRad). Relative
abundance of mRNA was calculated after normalization with
GAPDH or total PML. Analysis of viral transcripts.Total RNA was
isolated from HSV-1 infected PML stable transfectants using
Trizol (Invitrogen). First strand synthesis was performed using the
High capacity cDNA Reverse transcription Kit (Applied Biosys-
tems). Real-time PCR was performed using Cyber Green
(Invitrogen) and the following primer sets in conjunction with
Applied Biosystem’s 7500 Real Time PCR System: ICP0 F 59
AACGCCAAGCTGGTGTACCTGATA (sence), ICP0 R 59
AGCACCTCAAACATGCCTTTCACG (antisence), Us11 F 59
CTTCAGATGGCTTCGAGATCGTAG (sence), Us11 R 59
TGTTTACTTAAAAGGCGTGCCGT (antisence). Mouse 18S
ribosomal RNA primer set was obtained from SuperArray.
Indirect Immunofluorescence and confocal microscopy
Indirect immunofluorescent and confocal imagery were per-
formed using cells cultured on 12 mm circular glass coverslips
(thickness index of 1) in 6-well plates. Slide cultures were rinsed
three times with PBS, fixed for 1 hour with 4% paraformaldehyde,
rinsed three times with PBS, and permeablized with 0.5% Triton
X-100 for 15 min. After rinsing three times with PBS, and
blocking with a 5% solution of the appropriate serum diluted in
PBS, cells were incubated with primary antibody overnight at 4uC
(PG-M3 diluted 1:150). Bound antibodies were detected by
incubating the slide cultures with horse anti mouse Texas Red,
1:200 for 1 h at room temperature. For dual staining of PML &
ICP0, coverslips were incubated with 10% human serum, followed
by incubation with anti ICPO conjugated to Alexa Fluor 488
(Molecular Probes) diluted 1:600 in PBS. Cellular chromatin was
counter stained with DRAQ5, DAPI or Cytox orange (Molecular
Probes), rinsed, and mounted onto glass coverslips (AntiFade,
Molecular Probes). Indirect immunofuorescent images were
viewed on an Olympus fluorescence microscope and analysed
using Metaview software. Confocal images were examined with a
Zeiss LSM 510 confocal microscope at excitation wavelengths of
488, and 543nm. Data were collected with fourfold averaging at a
resolution of 1,02461,024 pixels.
Immunoprecipitation
For co-immunoprecipitation of V5- and myc-tagged PML
constructs, HEK293 cells were transiently transfected in 6-well
plates using Fugene 6 and a total of 1 mg plasmid DNA. Cells were
lysed 48 h post-transfection with IP buffer (20 mM Tris pH 8.0,
400 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 10 mM
NaF, 0.5% DOC, 1uM PMSF, and Protease Inhibitor Cocktail
(Sigma), and protein concentrations were determined and
normalized to achieve equivalent loading. Crude lysates were
pre-cleared with protein G-Sepharose beads (Amersham Biosci-
ences) and incubated with antibodies specific for V5 or myc.
Immune complexes were precipitated with protein G-Sepharose
beads followed by sequential washes in IP buffer. After the final
wash, the pellet was resuspended in sample buffer, and proteins
were resolved by SDS-PAGE (4–12% Bis-Tris NuPAGE gel) and
transferred to a PDVF membrane for immunoblot analysis using
HRP-conjugated V5 or Myc antibodies.
Virus infections and growth curve experiments
Stable B1041-1 cell lines containing PML I, PMLIb or vector
alone were seeded at ,5610
6 cells per well in 6-well clusters and
mock infected, or exposed to HSV-1 strain F or the recombinant
HSV-1 ICP0 null mutant virus R7910 diluted in mixture 199
(Gibco) supplemented with 1% calf serum. After 1 hr incubation at
37uC, monolayers were rinsed extensively, and replaced with
regular growth media. Cells were cultured at 37uC and harvested
for titration and for western analyses at times after infection
indicated in Results. For growth curve experiments, cells were
subjected to two freeze/thaw cycles, sonicated and serially diluted
in 199 medium containing 1% calf serum. Viral titers were
determined by standard plaque assay using VERO cells.
Preparation of cell lysates and immunoblotting
Whole cell lysates were obtained by rinsing cell monolayers
once with phosphate buffered saline (PBS), and disrupting cells in
150 ml whole cell lysate buffer (20mM Tris pH8, 1mM EDTA, 1%
Triton-X, 400mM NaCl, 10mM NaF, 0.5% deoxycorticosterone,
100 mM PMSF, and a protease inhibitor cocktail (Sigma). Protein
concentrations were quantitated using the Bradford assay
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boiling for 3 min in SDS loading buffer; loaded onto an 8 or 10%
SDS-polyacrylamide gel; and transferred to a PVDF membrane.
Membranes were blocked, and probed with the appropriate
antibody overnight at 4uC (ICP0 at 1:8000, Us11 at 1:4000, b-
Actin at 1:5000). The immunoblots were rinsed, and incubated
with secondary antibodies conjugated to horseradish peroxidase
(HPR) or alkaline phosphatase for 1–3 hr at room temperature.
Bound HRP conjugated antibodies were detected using enhanced
chemiluminescence (ECL plus, Amersham) and bound AP
conjugated antibodies were visualized by addition of the alkaline
phosphatase substrate buffer containing BCIP (5-bromo 4-chloro-
3-indolphosphate) and nitroblue tetrazolium (Sigma).
RNAi
MRC5 cells (0.5610
6) were co-nucleofected with 100 pmol si
RNA and 1 ug pUB6/V5-His (Invitrogen) using an amaxa
Nucleofector Device following the manufacture’s basic nucleofec-
tin protocol for primary mammalian fibroblasts (amaxa Inc.,
Gaithersburg, MD). 24h after electroporation, cells were treated
with 5ug/ml Blasticidin S HCl (Invitrogen) to kill all cells not
harboring the blasticidin resistant gene contained in the pUB6/
V5-His vector. Following 24 h of drug selection, cells were mock
infected or exposed to 1 PFU/cell of the HSV-1 (F) strain or the
HSV-1 ICPO-/- virus (R7910) based on a cell count taken from
cells subjected to both nucleoporation and drug selection. Proteins
and total RNA were harvested for Western blot and Real time
PCR analysis 24 h post infection.
A pre-annealed, custom siRNA was designed to specifically
target the PML Ib isoform. Both siRNA for PML Ib and a
negative control siRNA were purchased from Ambion. The
targeted nucleotides for PML Ib were as follows: 59-GACGUU-
GACCUGAGGAACGUU-39 (sense), 59 CGUUCCUCAGGU-
CAACGUCUU-39 (antisense).
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